ArticleRevista panamericana de salud publica = Pan American journal of public health2021
Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina.
Article in Revista panamericana de salud publica = Pan American journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 11 citations in OpenAlex.
- Biodegradation of benzalkonium chloride: effect of carbon substrate on microbial community structure and antimicrobial susceptibility.Biodegradation · 2026Article
- National Antimicrobial Consumption in Latin America and the Caribbean: Measurements and Results from 2019-2022.Antibiotics (Basel, Switzerland) · 2025Article
- Implementing national antimicrobial consumption in Latin America and the Caribbean: opportunities and lessons learned.Epidemiology and infection · 2025Article
- Article
- Epidemiological and microbiological characteristics ofFrontiers in pediatrics · 2024Article
- Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates inInterdisciplinary perspectives on infectious diseases · 2022Article
- Antimicrobial stewardship in Latin America: Past, present, and future.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe bacterial resistance and antimicrobial consumption ratio at the subnational level in Argentina during 2018, considering beta-lactams group as a case-study.
methodsAntimicrobial consumption was expressed as defined daily doses (DDD)/1000 inhabitants. Resistance of
resultsThe most widely consumed beta-lactams in Argentina were amoxicillin (3.64) for the penicillin sub-group, cephalexin (0.786) for first generation cephalosporins, cefuroxime (0.022) for second generation; cefixime (0.043) for third generation and cefepime (0.0001) for the fourth generation group. Comparison between beta-lactams consumption and bacterial resistance demonstrated great disparities between the six regions of the country.
conclusionsThe case-study of Argentina shows that antimicrobial consumption and resistance of the most common pathogens differed among regions, reflecting different realities within the same country. Because this situation might also be occurring in other countries, this data should be taken into account to target local efforts towards better antimicrobial use, to improve antimicrobial stewardship programs and to propose more suitable sales strategies in order to prevent and control antimicrobial resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.